AUG 27, 2019 12:44 PM PDT

A Skin Patch Might be the Most Effective Melanoma Treatment

WRITTEN BY: Tiffany Dazet

Researchers from the Massachusetts Institute of Technology (MIT) have developed a fast-acting skin patch that effectively delivers cancer-fighting medication to affected melanoma cells. Their research was presented yesterday at the American Chemical Society (ACS) Fall 2019 Meeting and Exposition. The entire presentation is in the video below.

A skin patch is ideal for melanoma treatment because traditional treatments are not fully effective or convenient. Medicated ointments don’t penetrate skin layers deeply enough, and although syringes deliver medicine efficiently, they’re painful and inconvenient for patient-use.

Microneedle patches are a painless and successful way to deliver treatment. They’re prepared with a layer-by-layer (LbL) coating methods, which covers surfaces with molecules of alternative positive and negative charges. Previous LbL methods created a very sticky film, causing the medication delivery time to last 15 to 90 minutes. Researchers feared that this long application time would lead to non-compliance by patients.

The team from MIT, led by Paula T. Hammond, Ph.D. and her graduate students Yanpu He and Celestine Hong, solved the problem of the prior microneedle patches by designing a new pH-responsive polymer. When tested in mice, this microneedle treatment produced nine times the antibody level compared to intramuscular injections and 160 times the antibody level compared to subcutaneous injections. They saw similar results when testing surgical samples of human skin.

In a statement from ACS, Yanpu He stated: “Our patch has a unique chemical coating and mode of action that allows it to be applied and removed from the skin in just a minute while still delivering a therapeutic dose of drugs. Our patches elicit a robust antibody response in living mice and show promise in eliciting a strong immune response in human skin.”

Hammond and her team are excited for the patch’s use by oncologists to fight melanoma, in addition to its use in fighting infectious diseases. Hammond told ACS reporters that, “We are using low-cost chemistry and a simple fabrication scheme to transform vaccination. Ultimately, we want to get a device approved and on the market.”

Sources: ACS, ACS Nano

About the Author
  • Tiffany grew up in Southern California, where she attended San Diego State University. She graduated with a degree in Biology with a marine emphasis, thanks to her love of the ocean and wildlife. With 13 years of science writing under her belt, she now works as a freelance writer in the Pacific Northwest.
You May Also Like
JAN 15, 2020
Health & Medicine
JAN 15, 2020
The "Normal" Body Temperature Has Decreased
Did you know that the standard human body temperature of 98.6 degrees Fahrenheit was established in 1868? A few modern studies have called this figure into...
JAN 15, 2020
Cardiology
JAN 15, 2020
Women's Blood Vessels Age Faster than Men's, Study shows
Around 75 million Americans have high blood pressure, or roughly 1 in every 3 adults. Now, new research has shown that women’s blood vessels age fast...
JAN 23, 2020
Health & Medicine
JAN 23, 2020
Yes, Stress Can Turn Your Hair Gray
Stress and gray hair have always been closely associated, and now, scientists from Harvard have discovered the physiological mechanism that validates this...
JAN 26, 2020
Cell & Molecular Biology
JAN 26, 2020
Using Stem Cells to Treat Chronic Pain
Scientists have used a mouse model to show that human stem cells could be used to engineer neurons that stop pain....
FEB 07, 2020
Health & Medicine
FEB 07, 2020
Could False Cannabis Information Online Be Harmful To Public Health?
Under federal law, cannabis is illegal and considered a class 1 drug, meaning that it is perceived to have no medical value, with a high potential for user...
FEB 12, 2020
Cannabis Sciences
FEB 12, 2020
Insurance for Cannabis? Coverage Remains Elusive
Cannabis use can carry a variety of benefits and risks for recreational consumers, patients, doctors and businesses. And where there is risk, there is ofte...
Loading Comments...